Lipolytic Peptides for Fat Loss, Explained
By Charles Kamen, MD, board-certified neurologist
AOD-9604 is a fragment of human growth hormone — specifically amino acids 176-191, the portion of the molecule responsible for fat-burning activity, separate from its growth-promoting effects. [1] It is one of the lipolytic peptides used to support fat loss inside a supervised weight-management plan.
Dr. Charles Kamen, MD, a board-certified neurologist at LiveNow Longevity in Las Vegas, offers lipolytic peptides as one tool within comprehensive weight-management protocols — never as a stand-alone shortcut. Individual results vary.
What Is AOD-9604?
AOD-9604 is a synthetic fragment of human growth hormone (hGH) made up of amino acids 176-191 — the tail end of the molecule that carries its fat-burning activity without the growth-promoting signal. [1] It was originally developed as an obesity treatment and studied for its effects on lipid metabolism.
Because it isolates the lipolytic (fat-releasing) domain of growth hormone, AOD-9604 is sometimes called fractionated GH — designed for fat-specific action, releasing stored fat while leaving the broader growth signals aside.
How Do Lipolytic Peptides Work?
Lipolytic peptides stimulate lipolysis — the breakdown of stored fat — and inhibit lipogenesis, the creation of new fat cells. AOD-9604 appears to act through the same receptor mechanisms as growth hormone but without its growth-promoting effects. [2] That selectivity is the theoretical basis for fat loss without the concerns tied to growth hormone use.
In practical terms, lipolysis frees fatty acids from fat cells to be burned for energy, while lipogenesis packs energy back into storage. A peptide that shifts the balance toward release aims to move body composition toward less stored fat — provided energy balance and activity support that goal.
What Does the Research Show?
Lipolytic peptides have been studied in several clinical trials, and early research showed promise for fat-mass reduction in obese subjects. However, the evidence base is not as extensive as it is for established weight-loss medications. [3] Honest expectation-setting is part of any responsible protocol.
That is the nuance Dr. Kamen raises with patients: promising is not the same as proven at the level of the newer weight-loss drugs. The data support a possible role for AOD-9604 as an adjunct — a helper alongside the fundamentals — not a primary therapy backed by large outcome trials.
How Lipolytic Peptides Compare to Other Fat-Loss Approaches
Lipolytic peptides are best understood next to the other options:
Why Losing Fat — Especially Visceral Fat — Matters
The goal of a lipolytic protocol is not a smaller number on the scale — it is losing fat mass, and especially the visceral fat packed around your organs. Visceral fat is the metabolically active depot most tied to insulin resistance and inflammation, so reducing it is what moves metabolic health and healthspan.
This is why Dr. Kamen frames fat loss as a metabolic-health project, not a cosmetic one. Trimming excess fat around the gut supports insulin sensitivity and eases inflammatory load — and is a large part of how people come to look younger through better health rather than any procedure. The peptide is only one lever; nutrition, muscle, sleep, and activity are the foundation it sits on.
How Are Lipolytic Peptides Administered?
Lipolytic peptides are typically given by subcutaneous injection, with common protocols involving daily or every-other-day injections over several weeks to months. [4] Dr. Kamen sets the specific protocol based on your goals and how you respond to therapy.
Unlike growth hormone, AOD-9604 is not associated with muscle growth, so its effect on lean mass is expected to be neutral — which makes adequate protein and resistance training important for holding onto muscle while you lose fat. Reported side effects are generally mild, such as injection-site reactions, headache, or fatigue, though long-term safety data remain limited. As a neurologist, Dr. Kamen watches symptoms like fatigue and monitors the whole picture throughout therapy.
Key Takeaways
- AOD-9604 is a growth-hormone fragment (amino acids 176-191), the portion that carries fat-burning activity.
- It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (new fat creation) without growth-promoting effects.
- Early trials show promise for fat-mass reduction in obese subjects, but the evidence base is less extensive than for weight-loss medications.
- It is best used as an adjunct to diet and exercise, not a replacement for comprehensive weight management.
- Administered by subcutaneous injection, typically daily or every other day for several weeks to months.
- Because it is muscle-neutral, protein intake and resistance exercise matter for preserving lean mass while losing fat.
Common Questions
Is AOD-9604 the same as growth hormone?
No. AOD-9604 is a fragment — amino acids 176-191 — of human growth hormone that carries its fat-burning activity without the growth-promoting effects, which is why it is sometimes called "fractionated GH." It targets the lipolytic role of the molecule while leaving the classic growth signals aside.
Do lipolytic peptides actually work for fat loss?
Early research shows some fat-loss benefit, with promise for fat-mass reduction in obese subjects, but the evidence is not as robust as for weight-loss medications like dual-hormone agonists. Dr. Kamen discusses realistic expectations and positions the peptide as an adjunct to diet and exercise, not a stand-alone solution.
Can lipolytic peptides help me lose belly and visceral fat?
The aim of a lipolytic protocol is losing fat mass — including the visceral fat around your organs that most affects metabolic health and healthspan. It will not spot-reduce one area, and it works only alongside nutrition, activity, and sleep, but reducing overall and abdominal fat supports insulin sensitivity.
What are the side effects of lipolytic peptides?
Reported side effects are generally mild and may include injection-site reactions, headache, and fatigue. Long-term safety data are limited, which is one reason Dr. Kamen supervises therapy closely, monitors how you feel throughout, and keeps the peptide inside a broader, physician-managed weight-management plan.
Will lipolytic peptides cause me to lose muscle?
Unlike growth hormone, AOD-9604 is not associated with muscle growth, so its effect on lean mass is expected to be neutral rather than harmful. To hold onto muscle while losing fat, adequate protein intake and resistance exercise remain important throughout therapy.
Can I stack lipolytic peptides, and how long is a course?
Yes. Lipolytic peptides are sometimes combined with other peptides, such as growth-hormone secretagogues, for enhanced body-composition effects, and Dr. Kamen builds safe stacking protocols. Treatment duration varies, typically running several weeks to months, with the protocol set and adjusted based on your response.
Lipolytic peptides like AOD-9604 may support fat loss — especially the visceral fat that matters most for metabolic health — but only as one part of a comprehensive, physician-guided plan. Discuss lipolytic peptides with Dr. Kamen to determine whether they fit your treatment plan.
References
- Ng FM, Sun J, Sharma L, et al. Horm Res. 2000;53(6):274-278. (Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone).
- Heffernan M, Summers RJ, Thorburn A, et al. Endocrinology. 2001;142(12):5182-5189. (Effects of human GH and its lipolytic fragment AOD9604 on lipid metabolism).
- Renke G, Chinellato L. Int J Mol Sci. 2026;27(9). (Therapeutic peptides in aesthetic, metabolic and endocrine conditions: effects, safety, and clinical evidence).
- Renke G, Chinellato L. Int J Mol Sci. 2026;27(9). (Therapeutic peptides in metabolic and endocrine conditions: administration and clinical considerations).
Wondering what’s right for you?
Get a straight answer from board-certified neurologist Dr. Charles Kamen, MD. The evaluation is $88 and is applied toward your protocol if you continue care.